Immunization and cardiovascular disease in Latin America. The CorVacc study: rationale and design

Fernando Wyss, Servicios y Tecnología Cardiovascular de Guatemala-CARDIOSOLUTIONS, Guatemala
Ricardo López-Santi, Hospital Italiano de la Plata, La Plata, Argentina
Daniel Piskorz, Unidad de Cardiología Sanatorio Británico, Rosario, Argentina
Shyla Gupta, University of Ottawa, Faculty of Medicine, Ottawa, Canadá
Ana Munera-Echeverri, Hospital General de Medellín, Medellín, Colombia
Pilar Lopez-Santi, Leiden University Medical Center, Leids Universitair Medish Centrum, Leiden, Holanda
Gonzalo Piskorz, Data IQ, Buenos Aires, Argentina
Vladimir Ulluauri, Hospital Metropolitano de Quito, Quito, Ecuador
Juan E. Gomez, Fundacion Valle de Lili, Unidad de Cardiología, Cali, Colombia
Mildren del-Sueldo, Clínica de Especialidades Villa María, Córdoba, Argentina
Claudia Almonte, CEMDOE Unidad de Cardiología, Santo Domingo, República Dominicana
Máxima Mendez, Cli-Lipid, Santo Domingo, República Dominicana
Osiris Valdez, Hospital Central de la Romana, La Romana, Republica Dominicana
Carlos I. Ponte-Negretti, Instituto Medico la Floresta, Caracas, Venezuela
Iván Romero-Rivera, Universidade Federal de Alagoas, Alagoas, Brasil
Adriana Puente-Barragán, Centro Medico Nacional XX de Noviembre, Ciudad de México, México
Raúl Villar, BUPA Integra Medica la Serena, La Serena, Chile
Edmundo Jordan, Hospital Pavía Santurce Cardiology Center, San Juan, Puerto Rico
Wistremundo Dones, Hospital Ryder Memorial, Humacao, Puerto Rico
Daniel Quezada, Hospital San Vicente de Paul, San José, Costa Rica
Ariel Arguello, Hospital Vivian Pellas, Managua, Nicaragua
Gonzalo Perez, Clinica Olivos, Buenos Aires, Argentina
Adrian Baranchuk, Kingston Health Sciences Centre, Queens University, Kingston, Canadá

Objectives: To determine the rates of vaccination against influenza and pneumococcal disease in the general population of the Americas, both healthy and sick, and to analyze the factors influencing these rates. Methods: The Inter-American Vaccination Registry of Influenza and Pneumococcus, (CorVacc Study) is a cross-sectional survey of the general population that will be enacted in 19 Latin American countries. A total of 34 questions will be given to consecutive patients aged 18 years or older through an online survey. Results: The data will be analyzed by country and region according to seven clusters: demographics, socioeconomic and educational level, cardiometabolic profile, cardiovascular interventions, medical follow-up and treatments, and COVID-19 vaccination status. The study will be conducted by the Prevention Council of the Inter-American Society of Cardiology. Conclusions: This study will provide insight into the impact of influenza and pneumococcus vaccinations in Latin American populations and the barriers preventing the immunization targets from being actualized. Hopefully, this will help to facilitate the development of targeted and focused health prevention strategies.

Keywords: Vaccines. Influenza. Pneumococcus.